EUR 1.24
(-2.97%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 6.54 Million EUR | -20.99% |
2022 | 8.28 Million EUR | -13.38% |
2021 | 9.56 Million EUR | 67.52% |
2020 | 5.7 Million EUR | 8.64% |
2019 | 5.25 Million EUR | 10.84% |
2018 | 4.74 Million EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 5 Million EUR | -9.67% |
2024 Q1 | 6 Million EUR | -8.19% |
2024 Q2 | 5.54 Million EUR | -7.74% |
2023 Q3 | 6.54 Million EUR | -13.18% |
2023 FY | 6.54 Million EUR | -20.99% |
2023 Q4 | 6.54 Million EUR | 0.0% |
2023 Q2 | 7.53 Million EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2022 Q2 | 8.88 Million EUR | 0.0% |
2022 FY | 8.28 Million EUR | -13.38% |
2022 Q4 | 8.28 Million EUR | 0.0% |
2022 Q3 | 8.28 Million EUR | -6.76% |
2022 Q1 | - EUR | -100.0% |
2021 Q4 | 9.56 Million EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 FY | 9.56 Million EUR | 67.52% |
2021 Q2 | 9.13 Million EUR | 0.0% |
2021 Q3 | 9.56 Million EUR | 4.74% |
2020 FY | 5.7 Million EUR | 8.64% |
2020 Q4 | 5.7 Million EUR | 0.0% |
2019 FY | 5.25 Million EUR | 10.84% |
2018 FY | 4.74 Million EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 5.5 Million EUR | -18.892% |
Nexstim Plc | 4.43 Million EUR | -47.553% |
Revenio Group Oyj | 18.7 Million EUR | 65.0% |